Windtree Therapeutics, Inc. (“Windtree” or the “Company”) (NasdaqCM: WINT), a biotechnology company focused on advancing early and late-stage innovative therapies for critical conditions and diseases, ...

FibroBiologics (FBLG) announced the filing of a patent application with the United States Patent and Trademark Office covering methods ...

This innovative method has the potential to unlock new treatment options for chronic conditions driven by mitochondrial dysregulation. HOUSTON, March 04, 2025 (GLOBE NEWSWIRE) -- FibroBiologics, Inc.

Windtree Therapeutics (WINT) announced that the United States Patent and Trademark Office has issued a Notice of Allowance for U.S. application ...

On February 28, 2025, the United States Patent and Trademark Office announced that it has rescinded the June 21, 2022, ...

A new trademark filing from Ford suggests the long-rumored four-door Mustang may finally be in the works. Ford recently filed ...

This innovative method has the potential to unlock new treatment options for chronic conditions driven by mitochondrial dysregulation. HOUSTON, March 04, 2025 (GLOBE NEWSWIRE) -- FibroBiologics, Inc.

This is Osteoboost’s 6th patent in the US. It is expected to launch in Q2 2025.

Can a drug that's used to treat malaria be repurposed to fight cancer? Researchers at The University of Texas at El Paso have ...

Just like German automakers, Hyundai wants to sell the impression of performance for those who can't afford the real thing.

Use of Saras' STILETM technology strengthens U.S. semiconductor packaging advancementsCHANDLER, Ariz., March 04, 2025 (GLOBE NEWSWIRE) -- S ...

On February 19, 2025, Adial announced patent number 12,226,401 was issued on February 18, 2025, by the United States Patent and Trademark Office (USPTO). The patent covers claims that focus on a ...